Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Hervé Tilly, Marie‐Pierre Moles‐Moreau et al.|Blood Advances|2021Cited by 51
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog studyMylène Duivon, Florence Joly, Sibille Everhard et al.|Breast Cancer Research|2024Cited by 15
R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa CentersVincent Camus, Hervé Tilly, Justine Lequesne et al.|Blood|2020Cited by 3
Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal studyMylène Duivon, Florence Joly, Sandrine Boyault et al.|Breast Cancer Research|2025Cited by 3
OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDYVincent Camus, Hervé Tilly, Alexandra Traverse‐Glehen et al.|Hematological Oncology|2021Cited by 0